Αποτελέσματα Αναζήτησης
3 Οκτ 2018 · Enter the CPT/HCPCS code in the MCD Search and select your state from the drop down. (You may have to accept the AMA License Agreement.) Look for a Billing and Coding Article in the results and open it. (Or, for DME MACs only, look for an LCD.) Review the article, in particular the Coding Information section.
11 Απρ 2016 · BRCA1 and BRCA2 genetic testing for susceptibility to breast or ovarian cancer is covered in adults as medically reasonable and necessary when there is a personal history of breast cancer (invasive breast cancer or ductal carcinoma in situ) and ANY of the following indications: Diagnosed at age 45 or younger;
3 Ιουν 2019 · The two MCG care guidelines most directly impacted by the changes are A-0499: Breast or Ovarian Cancer, Hereditary – BRCA1 and BRCA2 Genes (Sequence Analysis and Common Duplication or Deletion Variants) and A-0638: BRCA – Uncommon Duplication or Deletion Variants (Large Gene Rearrangements).
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Recommended test to confirm BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) syndrome. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval.
What is CPT 81162? CPT 81162 is a code used to describe the laboratory analysis of the full gene sequence and full duplication/deletion analysis of the BRCA1 and BRCA2 genes.
Source: Noridian Solutions, LLC MolDX BRCA1 and BRCA2 Genetic Testing LCD effective January 1, 2018 Effective January 1, 2018 Medicare Limited Coverage Tests. CPT Codes: Code Description 81162 . Brca1, brca2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletionanalysis
